Your browser doesn't support javascript.
loading
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.
Bellmunt Molins, Joaquim; García-Donas Jiménez, Jesús; Valderrama, Begoña P; Virizuela Echaburu, Juan Antonio; Hernando-Polo, Susana; Climent Durán, Miguel Ángel; Villa-Guzmán, José Carlos; Arranz Arija, José Ángel; Ostiategui, Mar Llorente; Milagro, Nuria Laínez; González-Del-Alba, Aránzazu; González, Begoña Mellado; Díaz, Enrique Gallardo; Gauna, Daniel Castellano; Santasusana, Montserrat Domènech; Herranz, Urbano Anido; Del Muro Solans, Xavier García; Pérez-Gracia, José Luis; Vázquez, Javier Puente; Morales-Barrera, Rafael; Pous, Albert Font.
Affiliation
  • Bellmunt Molins J; Medical Oncology, Hospital del Mar, Barcelona, Spain; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jbellmunt@imim.es.
  • García-Donas Jiménez J; Medical Oncology, HM Hospitales, Centro Integral Oncológico HM Clara Campal, Madrid, Spain.
  • Valderrama BP; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Virizuela Echaburu JA; Medical Oncology, Hospital Universitario Virgen de Macarena, Sevilla, Spain.
  • Hernando-Polo S; Medical Oncology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
  • Climent Durán MÁ; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Villa-Guzmán JC; Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Arranz Arija JÁ; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Ostiategui ML; Medical Oncology, Hospital General Universitario de Elda, Alicante, Spain.
  • Milagro NL; Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • González-Del-Alba A; Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • González BM; Medical Oncology Department, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Díaz EG; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.
  • Gauna DC; Medical Oncology, CIBER-ONC, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Santasusana MD; Medical Oncology, Althaia, Xarxa Assitencial de Manresa, Manresa, Spain.
  • Herranz UA; Medical Oncology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
  • Del Muro Solans XG; Medical Oncology, Institut Català d'Oncologia Hospitalet, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Spain.
  • Pérez-Gracia JL; Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Vázquez JP; Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pous AF; Medical Oncology, Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B∙ARGO), IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Clin Genitourin Cancer ; 18(6): 452-460, 2020 12.
Article in En | MEDLINE | ID: mdl-32565133

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Limits: Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos